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SUV420H2SUV420H1 and SUV420H2 are two highly homologous enzymes that methylate lysine 20 of histone
H4 (H4K20), a mark that has been implicated in transcriptional regulation. In this study, we present
the high-resolution crystal structures of human SUV420H1 and SUV420H2 in complex with SAM, and
report their substrate speciﬁcity. Bothmethyltransferases have a unique N-terminal domain and Zn-
binding post-SET domain, and prefer the monomethylated histone H4K20 as a substrate in vitro. No
histone H4K20 trimethylation activity was detected by our radioactivity-based assay for either
enzyme, consistent with the presence of a conserved serine residue that forms a hydrogen bond
with the target lysine side-chain and limits the methylation level.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Histone lysine methylation plays an important role in the regu-
lation of dynamic chromatin structure and chromatin template-
mediated biological processes, including transcription, DNA repair
and replication [1]. Histone lysine methylation is carried out by
histone lysine methyltransferases (HMT). In the human genome,
there exist about 50 histone lysine methyltransferases, and most
of them contain a SET domain as their catalytic domain [2,3]. So
far, six histone lysine methylation sites have been identiﬁed on his-
tone H3 (K4, K9, K27, K36 and K79) and histone H4 (H4K20), and
each of these lysine residues can be mono-, di-, or trimethylated
often with distinct functional consequences. For example, SETD7
(also known as SET7/9) is a histone H3 monomethylase speciﬁcally
methylating histone H3K4 [4], G9a is a histone H3K9 dimethylase
[5], SUV39H1 and SUV39H2 are histone H3K9 trimethylases [5],
and the three NSD family members (NSD1-3) primarily dimethy-
late histone H3K36 [6–8].H4K20 is the only lysine methylation site on histone H4, and is
conserved from yeast to human [9–13]. In asynchronous HeLa
cells, the global levels of H4K20me1, H4K20me2, and H4K20me3
methylation is approximately 10%, 80%, and 5%, respectively [14].
Methyltransferases that speciﬁcally methylate H4K20 include the
monomethylase SETD8 (or PR-Set7) [10–12], SUV420H1 and
SUV420H2, which are primarily H4K20 dimethylases [14–17].
Although NSD1, NSD2 and ASH1 have also been reported to be able
to methylate H4K20 in vitro [18–20], depletion of ASH1 or NSD1
did not affect global levels of K20H4me1, me2 or me3 [21]. Also
Gozani’s lab were not able to observe methylation activity of
NSD2 at H4K20 despite using multiple approaches [8].
The H4K20me1, H4K20me2, and H4K20me3 marks have been
linked to transcriptional repression and activation [22–27], DNA
repair [13,16,28–30], and pericentric heterochromatin formation
[15], respectively. L3MBTL1, L3MBTL2 and 53BP1 have all been
found to recognize H4K20me1 and H4K20me2 marks [22,23,30–
35]. L3MBTL1 is a MBT repeat containing protein, and its MBT do-
main was found to compact chromatin dependent on mono- and
di-methylation of H4K20 and H1BK26 [22]. In another report, the
association of L3MBTL1 with chromatin was shown to be speciﬁ-
cally dependent on the presence of H4K20me1, which is deposited
by the H4K20 monomethylase SETD8, and this association
promotes transcriptional repression [23]. It was also reported that
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H4K20 in vivo [14]. A similar result was observed for the product
of the Drosophila single Suv420 gene [36]. While it remains obscure
whether the histone H4K20 methyltransferases SUV420H1 and
SUV420H2 speciﬁcally generate H4K20me2 in the 53BP1-mediated
DNA damage pathway, 53BP1 in mammals and Crb2 in ﬁssion
yeast were demonstrated to interact with H4K20me2 through their
tandem Tudor domain, and promote DNA damage checkpoint sig-
naling at DNA double-strand break sites [13,21,28,30].
Suv420h1/h2-double-null mice are perinatally lethal; their
chromatin has virtually lost all H4K20me2 and H4K20me3 marks
and displays increased DNA damage repair defects, suggesting
that the SUV420H1 and SUV420H2 enzymes play an essential
role in genome integrity [16]. On the basis of gene knock-down
analysis, it was suggested that the H4K20me1 mark created by
the monomethylase SETD8 is the predominant and preferential
substrate for SUV420H1 and SUV420H2 in vivo, although
SUV420H1 and SUV420H2 could also utilize unmodiﬁed H4K20
as a substrate in vitro and in vivo [15,21].
In this study we show that SUV420H1 and SUV420H2 can
methylate both unmodiﬁed and monomethylated H4K20 peptides
with higher catalytic efﬁciency (kcat/Km) for monomethylated pep-
tides. Both enzymes were active with nucleosome as a substrate
but exhibited no detectable H4K20 trimethylation activity. Crystal
structures of SUV420H1 and SUV420H2 provided mechanistic in-
sights into their distinct substrate speciﬁcity and their inability
in histone H4K20 trimethylation. We also report on assay optimi-
zation for screening these proteins in a 384-well format, enabling
the scientiﬁc community to search for potent and selective inhibi-
tors (chemical probes) to further investigate the role of these pro-
teins in cells. Discovery of such compounds could provide an
opportunity to control the level of activities of these proteins in
cells and further investigate their involvement in cancers.
2. Materials and methods
2.1. Protein expression and puriﬁcation
DNA fragments encoding the catalytic domains of human
SUV420H1 (residues 63–335) and SUV420H2 (residues 2–248)
was sub-cloned into pET28-MHL vector (GenBank Deposition
ID: EF456735) [37], downstream of the poly-histidine coding re-
gion. The proteins were over expressed in Escherichia coli BL21
(DE3) codon plus RIL strain (Stratagene) by addition of 1 mM
isopropyl-1-thio-D-galactopyranoside and incubated overnight at
15 C. Harvested cells were resuspended in 50 mM HEPES buffer,
pH 7.4, supplemented with 250 mM NaCl, 5 mM imidazole,
2 mM b-mercaptoethanol, 5% glycerol. The cells were lysed by
passing through a microﬂuidizer (Microﬂuidics Corporation) at
20,000 psi. After clariﬁcation of the crude extract by high-speed
centrifugation, the lysate was loaded onto a 5 mL HiTrap Chelat-
ing column (GE Healthcare), charged with Ni2+. The column was
washed with 10 column volumes of 20 mM HEPES buffer, pH
7.4, containing 250 mM NaCl, 50 mM imidazole and 5% glycerol,
the protein was eluted with 20 mM HEPES buffer, pH 7.4,
250 mM NaCl, 250 mM imidazole, 5% glycerol. The proteins were
loaded onto a Superdex 200 column (26  60) (GE Healthcare),
equilibrated with 20 mM PIPES buffer, pH 6.5, and 250 mM NaCl.
TEV protease was added to combined fractions containing
SUV420H1 and SUV420H2 to remove His-tag. The proteins were
further puriﬁed to homogeneity by ion-exchange chromatogra-
phy. The mutants of SUV420H1 (residues 63–335) were gener-
ated by using QuikChange Site-direct Mutagenesis kit (Agilent
Technologies). All the mutants were expressed and puriﬁed as
described above.2.2. Crystallization
Puriﬁed SUV420H1 and SUV420H2 proteins (10 mg/mL) were
mixed with S-adenosyl-L-methionine (SAM) (Sigma) at 1:10 molar
ratio of protein:SAM and crystallized using the sitting drop vapor
diffusion method by mixing 1 lL of protein solution with 1 lL of
the reservoir solution containing 2.0 M sodium formate, 0.1 M Bis-
Tris propane, pH 7.0 (for SUV420H1), or 12% PEG 8000, 0.1 M
HEPES pH 7.2, 12% ethylene glycol (for SUV420H2).
2.3. Data collection, structure determination and reﬁnement
X-ray diffraction data for selenium crystal of SUV420H1 were
collected at 100 K at the peak wavelength of the selenium K
absorption edge (0.97904 Å) using synchrotron radiation at the
Canadian Macromolecular Crystallography Facility (CMCF) on
beamline 08ID-1 at the Canadian Light Source (Saskatoon, SK,
Canada), while data for native SUV420H2 crystal were collected
in-house using Rigaku FRE High Brilliance X-ray Generator with
R-AXIS IV detector. Intensities were integrated and scaled using
HKL2000 [38]. The structure of SUV420H1 was determined using
the single-wavelength anomalous dispersion (SAD) method utiliz-
ing the anomalous signal from selenium atoms present in the sele-
nomethionine-labeled protein crystal. The positions of 10 selenium
anomalous scatters were found with the program SHELXD [39] fol-
lowed by heavy atom reﬁnement and maximum-likelihood-based
phasing as implemented in the autoSHARP program suite [40].
Phase improvement by density modiﬁcation generated an inter-
pretable experimental SAD map, which allowed an initial model
to be built using the autotracing algorithm in the ARP/wARP pro-
gram [41]. Following several alternate cycles of restrained reﬁne-
ment against a maximum-likelihood target and manual
rebuilding using COOT [42], the improved model revealed clear
electron densities allowing placement of the bound ligand, S-aden-
osyl-methionine (SAM), and ordered solvent molecules. All reﬁne-
ment steps were performed using REFMAC [43] in the CCP4
program suite [44]. During the ﬁnal cycles of model building,
translation-libration-screw (TLS) parameterization [45] was in-
cluded in the reﬁnement of the ﬁnal model which comprised pro-
tein, SAM, Zn ions, and solvent molecules. The model of SUV420H1
was then used as search model for solving the structure of
SUV420H2 by molecular replacement using Molrep [46]. Data col-
lection and reﬁnement statistics are summarized in Table 2.
2.4. HMT enzyme assays
The peptides H4(1–24) (SGRGKGGKGLGKGGAKRHRKVLRD-K),
H4(1–24)me1, H4(1–24)me2 and H4(1–24)me3 were purchased
from Tufts University Core Facility. A lysine residue was added to
the C-terminal of the peptide for biotinylation. 3H-SAM and 96-
well Flash plate coated with streptavidin were obtained from Per-
kin Elmer. SAM2 Biotin Capture Membrane was obtained from
Promega (Cat. #V2861). Ecolite(+) Liquid Scintillation Cocktail
(product #188247505) was from MP Biomedicals. Methyltransfer-
ase activities of wild-type SUV420H1 and SUV420H2 and four mu-
tants (SUV420H1: Y306F, C305F, M253A, and F311A) were
measured using a radioactivity-based assay. In this assay 3H-SAM
was used as a methyl donor to methylate peptide substrates. Pep-
tide substrates were biotinylated to be captured through their
interaction with streptavidin using streptavidin-coated SAM2
Biotin Capture membranes. The assay conditions were optimized
for the wild-type and each mutant, and all experiments were per-
formed at linear initial velocities. The optimal concentrations for
all the SUV420H1 and SUV420H2 enzymes, with exception of
SUV420H1_C305F mutant, were 0.5 lM. For SUV420H1_C305F
Fig. 1. Overall structure of SUV420H1 and SUV420H2. (A) Schematic illustration of the domain structures of SUV420H1 and SUV420H2. In human cells, the SUV420H1 gene
has two isoforms and the two isoforms share the N-terminal SET domain. (B) Overall structure of SUV420H1. The N-terminal domain, SET domain and post-SET domain are
colored in grey, green and cyan, respectively. The cofactor SAM is shown in a stick model. The four cysteines bound to the Zn ion are also shown in sticks. (C) Overall structure
of SUV420H2 drawn in the same orientation as in B. (D) Superposition of SUV420H1 and SUV420H2 structures.
Table 1
Kinetic measurements of the enzymatic activities of SUV420H1, its mutants and SUV420H2.
Enzyme Substrate KmApp (lM) kcat (h1) kcat/Km (lM1 h1)
Peptide/Nucleosome SAM
SUV420H1 H41–24K20me0 3.4 ± 0.4 45 ± 6 2.8 ± 0.1 0.82
H41–24K20me1 1.7 ± 0.3 9.4 ± 2.2 3.8 ± 0.3 2.24
H41–24K20me2 No detectable activity
Nucleosome 0.3 ± 0.1 31 ± 6 1.2 ± 0.2 4
SUV420H2 H41–24K20me0 21 ± 2 39 ± 6 1.7 ± 0.1 0.08
H41–24K20me1 16 ± 2.8 43 ± 6 4.3 ± 0.3 0.27
H41–24K20me2 No detectable activity
Nucleosome 0.5 ± 0.1 9.5 ± 1.2 5.3 ± 0.1 10.6
SUV420H1-C305F H41–24K20me1 20 ± 1.5 83 ± 5 9.6 ± 0.3 0.48
SUV420H1-Y306F 9.7 ± 1.6 53 ± 4 7.0 ± 0.3 0.72
SUV420H1-F311A 8.5 ± 1.7 80 ± 12 7.0 ± 0.7 0.82
SUV420H1-G229F 17 ± 1.6 19 ± 3 4.6 ± 0.3 0.27
SUV420H1-G229Y No detectable activity
SUV420H1-W264A No detectable activity
SUV420H1-S251A No detectable activity
SUV420H1-F281A No detectable activity
Note: The kinetic parameters presented in this table are determined under conditions described in Experimental procedures and are considered apparent values (KmApp).
H. Wu et al. / FEBS Letters 587 (2013) 3859–3868 3861the enzyme concentration for all the assays was set at 2 lM. The
reaction was prepared in the ﬁnal volume of 30 lL. The reaction
mix contained 24 lL of buffer (20 mM Tris–HCl, 10 mM DTT, pH
8.0), and 3 lL of 66 lM 3H-SAM (diluted with cold SAM to achieve
the desired concentrations in each assay). The reaction was started
by adding 3 lL of a respective peptide substrate. The reaction mix-
tures were incubated for 30 min and were quenched with 30 lL of
7.5 M Guanidine-HCl. In case of peptide substrate, 7 lL of the reac-
tion mix containing Guanidine-HCl was transferred into a SAM2
Biotin capture membrane. Membranes were washed twice with5 mM NaCl and three times with deionized water. Membranes
were dried for 2 h in the open air. Scintillation cocktail was added
into each individual vial before reading the CPM (counts per min-
utes). Amount of the product was quantiﬁed by tracing the radio-
activity (CPM) measured by a Liquid Scintillation Counter 3385
from Packard Instruments). The HMT activity was then calculated
based on the amount of methylated peptide/nucleosome converted
by the HMTs.
To determine the Km values for SAM and peptide, SAM or pep-
tide was titrated into the reaction mix that contained a saturating
Table 2
Crystallography data and reﬁnement statistics.
SUV420H1 SUV420H2
PDB Code 3S8P 3RQ4
Data collection
Space group P1 P212121
Cell dimensions
a, b, c (Å) 46.4, 50.1, 74.8 34.7, 60.2, 126.6
a, b, c () 101.0, 108.1, 89.8 90, 90, 90
Resolution (Å)
(highest resolution shell)
50.00–1.85 (1.89–1.85) 50.00–1.80
(1.85–1.80)
Rmerge 6.8 (50.9) 11.9 (35.8)
I/sI 32.8 (2.6) 26.6 (2.5)
Completeness(%) 97.8 (96.8) 98.7 (83.3)
Redundancy 3.9 (3.9) 8.3 (3.4)
Reﬁnement
Resolution (Å) 33.90–1.85 50–1.80
No. reﬂections 52,470 24,269
Rwork/Rfree 18.7 / 21.2 0.178/0.221
No. atoms
Protein 1,876 1,943
Cofactor 54 15
Zn 2 1
Water 270 232
B-factors (Å2)
Protein 28.5 18.8
Cofactor 23.5 12.2
Zn 27.5 15.0
Water 36.6 30.4
RMSD
Bond lengths (Å) 0.010 0.014
Bond angles () 1.2 1.4
Ramachandran plot % residues
Favored 90.0 91.4
Additional allowed 10.0 8.7
Generously allowed 0.0 0.0
Disallowed 0.0 0.0
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ration of the second substrate was reached by ﬁxing its concentra-
tion at 5 times of its respective Km value. The Km values were
calculated using a one site saturation equation using Sigma Plot
software (Systat Software, Inc., CA). Standard deviations were cal-
culated from three independent experiments. To calculate the kcat
values for all the enzymes, standard curve was generated using
labeled methylated H3 (1–25). To obtain labeled methylated H3
(1–25), 2 lM of H3 (1–25) substrate was incubated with 2 lM
hot SAM and 200 nM G9a for 3 h to ensure that every peptide is
methylated. The reaction mix was quenched as described above
and standard curve was generated by using a serial dilution of
the G9a/Peptide/SAM mixture and reading the CPM. All the exper-
iments were performed in triplicates. Enzyme assays with nucleo-
some as a substrate was performed using a ﬁlter-based assay as
previously described in Yu et al. [47].
3. Results and discussion
3.1. Enzymatic activity of SUV420H1 and SUV420H2
The SUV420 family of histone H4K20 methyltransferases was
ﬁrst isolated and characterized by Jenuwein’s lab in 2004 [15].
There are two Suv420 genes in vertebrates, i.e., Suv420h1 and
Suv420h2 (Fig. 1A). In human cells, SUV420H1 exists as two alter-
natively spliced isoforms, which share the N-terminal SET-domain
containing catalytic domain and function in substantially different
chromatin locations (Fig. 1A) [48]. Although SUV420H1 and
SUV420H2 preferentially dimethylate H4K20, they also
mono- and trimethylate this residue [15,21,49]. These two proteins
have been reported to dimethylate about 80 and 90% of totalhistone H4 in HeLa and S2 cells, respectively. However, they show
trimethylation activity in speciﬁc sites in chromatin [21,48]. High-
est H4K20 methylation level has been reported during mitosis that
has been proposed to enable the transcriptionally silent state of
genes [11,14,50]. At the same time, trimethylation of H4K20 in
mammalian tissues has been reported to be associated with aging
[51]. In order to characterize the enzymatic activity of these two
H4K20 methyltransferases quantitatively, we cloned and puriﬁed
the catalytic domains of both SUV420H1 (residues 63–335) and
SUV420H2 (residues 2–248), which yielded well-behaved proteins
for enzymatic characterization and crystallographic studies (Sup-
plementary Fig. 1).
We developed and employed a radioactivity-based assay to
evaluate the substrate speciﬁcity of these two proteins as de-
scribed in Materials and methods. In this assay we monitored
transfer of the methyl group from 3H-SAM to peptide substrates.
Both enzymes are most active at pH 8.0 and in assay conditions
with no NaCl (Supplementary Fig. 2). They also tolerate well the
presence of up to 5% DMSO (<15% decrease in activity) and 0.05%
triton (no effect). Using the optimized conditions, we determined
the kinetic parameters for both SUV420H1 and SUV420H2 activity
with peptides corresponding to residues 1 to 24 of histone H4 with
different H4K20 methylation states (Table 1).
Our data demonstrate that SUV420H1 and SUV420H2 mono-
and di-methylate H4K20 but exhibit no detectable H4K20 trime-
thylation activity (Table 1, Supplementary Fig. 3). Although there
is no dramatic difference in the Km and kcat values between unme-
thylated and monomethylated peptide substrates for either pro-
tein, both SUV420H1 and SUV420H2 showed about 3 times
higher catalytic efﬁciency (kcat/Km) for monomethylated H4K20
substrate. This is consistent with previous reports that SUV420H1
and SUV420H2 preferentially dimethylate histone H4K20, and
form only small amounts of H4K20me3 in vivo [15,21]. Consider-
ing low kcat values even with dimethylated H4K20 as a substrate,
trimethylation activity of these two enzymes may be below the
detection limit of our assay. Presence of other interacting proteins
in cells may also be required to further activate trimethylation
function of these two proteins [15]. Both proteins were also active
with the recombinant nucleosome as a substrate with kcat values of
1.2 ± 0.2 h1 and 5.3 ± 0.1 h1 for SUV420H1 and SUV420H2,
respectively (Table 1 and Supplementary Fig. 4).
3.2. Overall structures of SUV420H1 and SUV420H2
In order to understand the substrate speciﬁcity of SUV420H1
and SUV420H2, we determined the crystal structures of the cata-
lytic domains of human SUV420H1 and SUV420H2 in complex
with the cofactor SAM, using the same constructs we used for
enzymatic assays (Fig. 1B–D). The crystal structure of SUV420H1
was solved at 1.85 Å resolution by single-wavelength anomalous
dispersion (SAD) method using a seleno-methionine substituted
SUV420H1 crystal (Fig. 1B). The crystal structure of SUV420H2
was solved by molecular replacement to 1.8 Å resolution
(Fig. 1C). Detailed crystal diffraction data and reﬁnement statistics
are shown in Table 2.
Given that the catalytic domains of SUV420H1 and SUV420H2
share 65% sequence identity (Fig. 2A), it is not surprising that their
structures are also highly conserved with an RMSD of 0.5 Å over all
the aligned Ca atoms (Fig. 1D). The overall structures of the
catalytic domains of SUV420H1 and SUV420H2 consist of three
subdomains (Fig. 1): an N-terminal helical domain (referred to as
N-domain thereafter), a SET domain and a Zn-binding post-SET do-
main. Compared to SUV420H2, SUV420H1 has a bigger N-domain
as shown by a 22-residue insertion between the ﬁrst and second
helices; the majority of these residues were not observed in the
crystal structure due to crystallographic disorder (Fig. 2A).
Fig. 2. (A) Structure-based sequence alignment of SUV420H1 and SUV420H2. The secondary structure elements of SUV420H1 are shown on top of the sequence, with
cylinder represent helixes and arrows represent strands. The identical residues are colored in red, very similar in green, similar in blue and the rest are in black. Residues Y306
(SUV420H1) and F216 (SUV420H2) are highlighted. (B) and (C) Comparison of SUV420H1 (PDB 3S8P) and G9a (PDB 2O8J) Zn-binding domain. The Zn ion is shown in sphere,
while the cysteines are shown in sticks with the three from the post-SET domain colored in cyan and the one from the SET domain in green. D and E. Comparison of the N-
domain of SUV420H1 (grey) with the protein phosphatase PP2C (left, orange. PDB: 1A6Q), and T4 RNA ligase (right, orange. PDB: 2HVR).
H. Wu et al. / FEBS Letters 587 (2013) 3859–3868 3863Although the SET domains of SUV420H1 and SUV420H2 share a
low sequence identity with other solved SET domain methyltrans-
ferases (identity ranging from 8% to 22%), they are highly con-
served in structure. The SET and post-SET domains form apseudo-knot, similar to other SET domain structures [52]. The
SET domains harbor the active site, and both the SET and post-
SET domains are involved in substrate and cofactor binding
(Fig. 1) [52].
Fig. 3. Multiple sequence alignment of SET domains from different human histone methyltransferases. The cysteines bound to Zn ion are highlighted in cyan. The active site
residues are boxed.
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domain and N-domain
So far, over 20 SET domain methyltransferase structures have
been solved. Like other Zn-binding post-SET domains, the Zn ion
in SUV420H1 and SUV420H2 is bound by four cysteine residues,
i.e., three cysteine residues from the post-SET domain and a fourth
cysteine from the knot-like structure of the SET domain close to the
SET domain active site [53]. On the basis of structural comparison
and sequence alignment, we found that SUV420H1 and SUV420H2
have a unique Zn-binding domain (Fig. 2B, C and Fig 3). The three
cysteine residues from the post-SET domains of SUV420H1 and
SUV420H2 have a CxCxxC motif (x represents any residue), while
the other SET domains have a CxCxxxxC motif (Fig. 3). Structural
comparison shows that the third cysteine residue is located in a
a helix in the post-SET domains of SUV420H1 and SUV420H2,
whereas the third cysteine residue in other post-SET domains is lo-
cated in a circular loop, which requires more residues to loop back
the third cysteine residue to coordinate the Zn ion (Fig. 2B and C).
SUV420H1 and SUV420H2 have a helix bundle as their N-
domain, which consists of 5 (SUV420H2) or 6 (SUV420H1) helices
(Fig. 2D and E). This N-domain is unique compared to other solved
SET domain methyltransferase structures. A search of the protein
structure databank using the DALI server revealed that the protein
serine/threonine phosphatase PP2C and the RNA ligase Rnl2 have aFig. 4. Active site of SUV420H1. SUV420H1 and SUV420H2 have a unique structural bul
Like other SET domain proteins, SUV420H1 and SUV420H2 also have an aromatic pocket,
the active site of SUV420H1 (green) and GLP (pink, PDB 2RFI) is shown in the bottom righ
in yellow.similar domain [54,55] (Fig. 2D and E). In PP2C, this domain is lo-
cated far away from the catalytic site and is not directly involved in
catalysis, although it may play some role in substrate speciﬁcity
[54]. In Rnl2, the helix bundle domain is also away from the active
site, but it is crucial for activity [55]. On the basis of the solved SET
domain methyltransferase structures, the N-domain seems to be
very diverse, and appears to be a unique and deﬁning feature of
histone methyltransferases, which prompts us to propose that
incorporation of structurally divergent domains to the N terminus
of the catalytic SET domain may confer different biochemical spec-
iﬁcity to the various members of histone methyltransferases. This
hypothesis requires further investigation in the future.
3.4. Active sites of SUV420H1 and SUV420H2
Based on available structures, the substrate lysine of SET-
domain methyltransferases is generally surrounded with one or
more polar side-chains that restrain the rotational freedom of the
methyl-accepting nitrogen, which is necessary to align its lone pair
with the scissile bond of the cofactor’s sulfonium group. Rotational
freedom–and therefore methylation level–is inversely correlated
with the number of polar side-chains surrounding the substrate
lysine. For example, mutating Y245 or Y305 in SETD7 to alanine
changes SETD7 from a monomethylase to trimethylase [4,53].
Mutating F281 to tyrosine in Dim-5 converts Dim-5 to onlyge near the active site. A close-up view of the bulge is shown in the top right panel.
which presumably would accommodate the target lysine K20 of H4. Comparison of
t panel. The di-methyllysine from mouse SUV420H2 structure (PDB 4AU7) is colored
3866 H. Wu et al. / FEBS Letters 587 (2013) 3859–3868produce lower methylation states of histone H3K9 [53]. Our effort
to generate crystals of SUV420H1 and SUV420H2 in complex with
a substrate was not successful, but when we superimposed the
crystal structures of SUV420H1 and SUV420H2 with the complex
structure of GLP-H3K9me2 peptide [56], we found that, like GLP,
SUV420H1 and SUV420H2 harbor an aromatic pocket, which pre-
sumably would accommodate the target lysine K20 of histone
H4, which is conﬁrmed by the recently available mouse SUV420H2
structure in complex with a histone H4K20 peptide (PDB code:
4AU7) (Fig. 4). Interestingly, a glycine G229 in SUV420H1 (G140 in
SUV420H2) occupies the position corresponding to Y1124 in GLP,
thereby generating extra space next to the methyl-accepting nitro-
gen. One potential explanation is that a negatively charged residue
E225 in SUV420H1 (E136 in SUV420H2) is present at the beginning
of the bulge. If E225 took the same conformation like other SET do-
mains, E225 would be pointing toward a hydrophobic core in place
of L227, which is not favored (Fig. 4). Although SUV420H1 and
SUV420H2 lack an aromatic residue at the G229 position
(SUV420H1), they harbor an aromatic residue at W264 (SUV420H1)
or W174 (SUV420H2), which occupies a similar position to Y1124 in
GLP (Fig. 4). The importance of these active site residues is revealed
by our mutagenesis data, showing that G229Y, W264A, S251A, and
F281A SUV420H1 mutants are no longer active. The Km values for
monomethylated peptide with G229F (17 ± 1.6 lM) and F311A
(8.5 ± 1.7 lM) mutants were higher than that for the wild-type
SUV420H1 (1.7 ± 0.3 lM), and their catalytic efﬁciencies decreased
by about 8 and 3 times, respectively (Table 1).
3.5. Trimethylation of H4K20 by SUV420H1 and SUV420H2 is too low
to be detectable in vitro
SETD7 is a histone H3K4 monomethylase. Crystal structure of
SETD7 in complex with a histone H3K4 peptide reveals that Y245Fig. 5. Superposition of the active sites of SUV420H1 (green), SUV420H2 (human, cyan
SETD8 (purple, PDB 1ZKK). S251 in SUV420H1 (S161 in SUV420H2) points to the same p
clariﬁcation, only the cofactor SAH and the histone peptide from the SUV420H2 structuforms a hydrogen bond with the target lysine through its side chain
hydroxyl group, which would not only stabilize the target lysine,
but also prevent methylation in this position [4]. Mutating the
Y245 to alanine in SETD7 allows SETD7 to trimethylate the histone
H3K4 peptide [4]. Consistently, mutating the corresponding resi-
due in G9a (Y1067) could also enable G9a to carry out trimethyla-
tion [56], although, in both cases, their enzymatic activity is
severely diminished. In the crystal structures of SUV420H1 and
SUV420H2, a glycine residue (G229 in SUV420H1) resides in the
position corresponding to Y245 in SETD7. Interestingly, a serine
residue in SUV420H1 and SUV420H2 points to the same position
as Y245 in SETD7 (Fig. 5). Presumably, this serine residue will also
form a hydrogen bond with the target lysine through its hydroxyl
group. Strikingly, based on the recently released structure of
mouse SUV420H2 in complex with a histone H4K20 peptide and
S-Adenosyl-L-homocysteine (SAH) (PDB code: 4AU7, Supplemen-
tary Fig. 5), which has very high sequence identity (82%) and struc-
ture conservation (with a RMSD of 0.58 Å) with its human
counterpart, the serine residue S161 in SUV420H2 (S251 in
SUV420H1) does form a hydrogen bond with the target lysine
through its hydroxyl group (Fig. 5 and Supplementary Fig. 5).
Therefore, this structural feature provides a nice explanation for
the observation that SUV420H1 and SUV420H2 have virtually no
trimethylation activity on H4K20. The importance of this serine
residue in catalysis is also reﬂected by the total loss of activity
when S251 is mutated to alanine in SUV420H1 (Table 1). Similarly,
mutating the corresponding residue in SETD8 (Y245) also abol-
ished its activity [57]. Taken together, the conserved serine residue
in SUV420H1 and SUV420H2 plays two roles: (1) It aligns the tar-
get lysine for mono- and di-methylation. (2) It forms a hydrogen
bond with the target lysine and controls the methylation product.
In summary, in this work, we presented the high-resolution
crystal structures of SUV420H1 and SUV420H2 in complex with), SUV420H2 (mouse, limon), GLP (pink, PDB 2RFI), SETD7 (brown, PDB 1O9S) and
osition as Y245 in SETD7, Y245 in SETD8 and Y1124 in GLP (or Y1067 in G9a). For
re (PDB 4AU7) are shown.
H. Wu et al. / FEBS Letters 587 (2013) 3859–3868 3867SAM, and characterized their substrate selectivity and product
speciﬁcity. Our crystal structures and mutagenesis data provide in-
sight to why both SUV420H1 and SUV420H2 are less active with
unmodiﬁed histone H4K20 peptide (3 times lower catalytic efﬁ-
ciency) and show no trimethylation activity. By structural compar-
ison, it is also revealed that SUV420H1 and SUV420H2 have unique
Zn-binding post-SET and N-terminal domains. Although
SUV420H1 and SUV420H2 have similar substrate speciﬁcities
and potentially could be redundant, they may have different divi-
sion of labor in the cell, or be under different expression regula-
tions. Since SETD8 is more than 250-fold more active than
SUV420H1 and SUV420H2, monomethylation of H4K20 by SETD8
may signiﬁcantly contribute to the functionality of these two pro-
teins in cells, such as involvement of SUV420H1 in the DNA repair
pathway.
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